John D. Wass CAI

John Wass is responsible for directing a services portfolio catered to helping the industry rapidly deploy safe, efficacious drug products to the market and maintain strategic on-market product supply. Over the past 13 years he has participated in many stages of the product development lifecycle from concept to new market commercialization, and has implemented enterprise quality data management and manufacturing process control systems in support of these product processes. John focuses primarily on large, complex tech transfer programs and has transferred numerous products from CMOs to In-house domestically, as well as within network to international greenfield facilities employing a retrospective QbD approach. Previously he served in site project lead roles focusing on off-market and drug shortage product re-launches, as well as global expansion of on-market products to new international markets. Prior to CAI, he worked for a start-up medical device company specializing in the development of in situ polymerizing hydrogels as internal sealants, where he actively participated in the development, characterization, and commercialization of novel products. John earned his B.Sc. in Biochemistry at the University of Virginia, where he researched solid phase extraction techniques for application in a fully integrated microdevice capable of genetic analysis.